Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

Complement blockade by eculizumab is clinically effective in hemolytic paroxysmal nocturnal hemoglobinuria. However, the response is variable and some patients remain dependent on red blood cell transfusions. In 72 patients with hemolytic paroxysmal nocturnal hemoglobinuria on eculizumab we tested t...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Rondelli, Tommaso, Risitano, Antonio M., de Latour, Régis Peffault, Sica, Michela, Peruzzi, Benedetta, Ricci, Patrizia, Barcellini, Wilma, Iori, Anna Paola, Boschetti, Carla, Valle, Veronica, Frémeaux-Bacchi, Veronique, De Angioletti, Maria, Socie, Gerard, Luzzatto, Lucio, Notaro, Rosario
Формат: Artigo
Язык:Inglês
Опубликовано: Ferrata Storti Foundation 2014
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912955/
https://ncbi.nlm.nih.gov/pubmed/24038027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.090001
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы